Introduction: Pericatheter bleeding (PB) following tunneled hemodialysis catheter (THC) placement is a common phenomenon. In addition to complicating securement of the THC, the PB may loosen the adhesive catheter dressing and delay wound healing. The primary aim of this study was to determine whether epinephrine-containing local anesthetics rather than plain ones reduce superficial PB after THC placement.
INTRODUCTION
Insertion of tunneled hemodialysis catheters (THC) is one of the most frequently performed invasive procedures in interventional radiology practice and critical care settings.
1,2 Pericatheter bleeding (PB) following THC placement is a common phenomenon, which might lead to a hematoma formation if disregarded. One practical solution for this problem and its possible further complications is to perform manual compression onto the catheter site. Nonetheless, the manual compression, particularly in patients with PB, can be time-consuming for healthcare professionals and also uncomfortable for the patients. 3, 4 Local anesthetics such as lidocaine are commonly used to reduce pain during the THC placement.
1, 5 In addition, there are commercially available epinephrine-containing local anesthetic drugs in use. Epinephrine is a potent vasoconstrictor, prolonging anesthesia by slowing vascular uptake of the lidocaine and reducing the bleeding into the wound. [5] [6] [7] [8] [9] It would be a simple solution to use epinephrine-containing local anesthetics during the THC placement to reduce possible PB and its possible complications.
To date, although there are a few studies that have investigated hemodynamic effects of epinephrinecontaining lidocaine in various procedures, 6, [10] [11] [12] [13] no research has been found as to the THC placement. The aim of this study was to determine whether the epinephrine-containing lidocaine reduces the PB after THC placement.
METHODS Ethics
The study was approved by our Institutional Review Board (IRB). Written informed consent was waived by IRB.
Study design and patients
We retrospectively reviewed our prospectively gathered interventional radiology database to extract patients who underwent THC insertion between March 2017 and October 2017. We divided patients into two groups: group 1, patients receiving prilocaine hydrochloride (HCl) and group 2, patients receiving lidocaine HCl with epinephrine. Then, we analyzed all patients' demographics, relevant clinical and laboratory data, and observations between the groups in terms of PB.
The interventional radiologist, radiology resident, nurse, and patient were blind to the anesthetic solution used. It was only known by the radiology technician. The patients were randomly assigned.
Patients' inclusion criteria were as follows: (i), THC insertion for the first time; (ii), coagulation parameters within the normal range; and (iii), no evidence of active infection. Patients were excluded for: (i), THC insertion to veins other than internal jugular; (ii), exchange of the preexisting THC in the internal jugular vein; (iii), coagulation parameters were out of the normal range or patients using anticoagulant drugs; and (iv), evidence of active infection.
Regional anesthetics
Two types of local anesthetics were used: (i), 2% prilocaine HCl (20 mL) without epinephrine and (ii), 2% lidocaine HCl with 1:80,000 epinephrine (1 mL/6 kg and complete to 20 mL with 0.9% NaCl).
Catheters
Jugular THCs are straight and made of polyurethane (Hemostar Long-Term Hemodialysis Catheter Standard Kit, Bard Access Systems, Salt Lake City, USA). THC has two lumens with a diameter of 14.5 F. The length alters (19, 23 , or 27 cm) according to the body size of the patient. The distance between the internal jugular venous puncture point and the tip of the tunnel is measured using a guidewire. The dacron cuff of the permanent catheter is located about 5 cm from the exit site, providing a barrier for infections and stabilization by triggering fibrous tissue formation in the surrounding tissue.
Preoperative assessment
Before the procedure, all patients were examined for demographic parameters (age, gender, and body-mass index), catheter implantation sites, prior history of central venous catheter (CVC) insertion, prior history of anticoagulant drug usage, and complications within the first 3 days. Before insertion of the catheter, all patients had their complete blood count, activated partial thromboplastin time (aPTT), international normalized ratio (INR), and preoperative systolic blood pressure (SBP) checked.
Catheter placement
Placement of the THCs was performed by a senior interventional radiologist (INM) along with a 3-5-year radiology resident.
All catheters were placed with conscious sedation and local anesthesia, with use of the strict aseptic technique according to our institution's operating room guidelines. A single dose of antibiotic, cefazolin 1 g or, in case of documented cephalosporin or penicillin allergy, clindamycin 600 mg, was given intravenously before catheter placement.
While the patient was lying in supine position, internal jugular vein puncture was performed under ultrasound (US) guidance with use of a linear probe. Selected region and surrounding area were covered with surgical cloth after skin sterilization. Subcutaneous prilocaine (2 cc in all patients) was used for local anesthesia of the cervical puncture site. After local anesthesia, the internal jugular vein was punctured 0.5-1 cm lateral to the carotid artery. The guidewire was advanced through the puncture needle and then the needle was removed. After the venous puncture and insertion of the guidewire, local anesthesia was applied to prepare the tunnel by subcutaneously injecting the lidocaine (1 mL/6 kg and complete to 20 mL with 0.9% NaCl) or prilocaine (20 mL) containing products on the pectoral area. All injections were administered with an 18G needle and a 20 mL syringe. A #11 blade was used to create a 5 mm incision on the chest wall at the desired entry site on the chest, followed by formation of a tunnel to the site of entrance of guidewire through the skin by a tunneling trocar attached to the end of the catheter and moving the catheter within this tunnel. After dilation of the soft tissues around the guidewire and insertion of the peel-away sheath, the catheter was inserted into the superior vena cava followed by peeling the sheath. Fluoroscopy was used to check the advance of the catheter in the superior vena cava and to confirm the final position of the catheter tip in the right atrium. The catheters were secured at the skin, then flushed and filled with heparin solution (1000 IU/mL). A sterile dressing was affixed after application of povidone ointment. Hemodynamic parameters (systolic-diastolic blood pressure and heart rate) were recorded 5 minutes after the local anesthesia.
Evaluation of pericatheter bleeding
PB was defined as (i) any amount of blood leakage from the catheter side after the procedure that requires manual compression, or (ii) color change in gauze due to visible bleeding after the dressing is closed.
Presence of PB was evaluated by the interventional radiologist's and nurse's observation. In case of PB, it was controlled by manual gauze compression. In patients without PB, no manual compression was needed. Patients were followed for half an hour by nurses under the interventionist's supervision in terms of complications (late onset PB, subcutaneous hematoma, hypotension, etc.). Patients with no complications during followup were discharged. In addition, patients were also strictly warned to apply immediately when they encountered any PB sign around the catheter.
Statistical analysis
The data analysis was performed using SPSS version 20 (Chicago, IL). To determine the group differences, independent samples t-test or Mann-Whitney U test was used for continuous variables and Fischer's exact test was used for categorical variables. In addition, a binomial logistic regression analysis was performed to determine the difference between PB complication at catheter exit site (a dichotomous dependent variable) and regional anesthetic drugs (an independent variable with two groups: prilocaine [group 1] vs. epinephrine-containing lidocaine [group 2]) while controlling for other pertinent independent variables (aPTT and INR, postoperative SBP level). Linearity of the continuous variables with respect to the logit of the dependent variable was assessed via the Box-Tidwell procedure. A Bonferroni correction was 
Findings
There were 24 males and 22 females with a mean age of 61.8 AE 14.8 (range; 25-84). In 24 patients, epinephrinecontaining lidocaine was used for regional anesthesia before THC placement. In the remaining 22 patients, prilocaine was used. In total, 10 patients had PB within 24 hours. Of those, nine patients were in the prilocaine group (group 1) and one in the epinephrine-containing lidocaine group (group 2). The group differences in patient's demographics, pertinent pre-procedural clinical and laboratory results, and postprocedural PB complication are presented in Table 1 . Postoperative SBP and PB were found to be statistically significantly different between the patient groups based on the type of regional anesthetic drugs used, P = 0.008, and P = 0.003, respectively. There was a statistically significant difference in change of preoperative and postoperative SBP between anesthetic drug groups used, with epinephrine-containing lidocaine group (group 2) being lower than prilocaine group (group 1), (mean difference, −14.2; 95% confidence interval, −18.1 to −7.2), t(43.233) = 4.701, P < 0.001. In the Box-Tidwell procedure, all continuous independent variables were found to be linearly related to the logit of the dependent variable. There were two studentized residuals with values of 10.372 and −1.643 standard deviations, which were kept in the analysis. The binomial logistic regression model was statistically significant, χ 2 (4) = 15.623, P = 0.004. The model explained 44.4% (Nagelkerke R 2 ) of the variance in PB and correctly classified 84.8% of cases. Sensitivity was 40%, specificity was 97.2%, positive predictive value was 80%, and negative predictive value was 85.3%. Of the five predictor variables, only one was statistically significant: regional anesthetic drugs, P = 0.009. Use of prilocaine had 59.7 times higher odds in the likelihood of PB after THC placement. Use of epinephrine-containing lidocaine is associated with a reduction in the likelihood of PB (Odds ratio = 0.017). Table 2 shows the results of the binomial logistic regression analysis.
DISCUSSION
In this study, we retrospectively determined the effects of epinephrine-containing lidocaine and prilocaine on PB after THC placement. Use of prilocaine had higher odds in the likelihood of PB after THC placement. Meanwhile, use of epinephrine-containing lidocaine is associated with a reduction in the likelihood of PB. Lidocaine 2% alone is considered safe when used in small quantities. Its onset of action, when infiltrated locally, is within seconds and its duration of action is generally 30-60 minutes. 14, 15 Epinephrine, on the other hand, is the most studied and widely used vasoconstrictor. 9, 10, [16] [17] [18] Epinephrine is also available with other local anesthetics as a mixture. There are several benefits of adding a vasoconstrictor to a local anesthetic: (i), improvement in the duration and quality of anesthesia 19 ; (ii), reduction of blood loss throughout the operation 20 ; (iii), reduction in the peak plasma concentration of the anesthetic agent 21, 22 ; and (iv), decrease in the minimum concentration of anesthetic that is necessary for nerve block. 23 Traditionally, subcutaneous infiltration of epinephrine-containing lidocaine was safely and routinely used in craniotomy to reduce blood flow in the scalp and minimize intraoperative blood loss. 24, 25 We can see similar studies, especially in the past, in the field of dermatology and dentistry. 6, 12, 16, 20, 26 In our study, we used a The variable "RAD" represents "prilocaine" b Odds ratio (OR) for epinephrine-containing lidocaine in the likelihood of PB is 0.017 (1/59.571). OR = odds radio; CI = confidence interval; RAD = regional anesthetic drug; aPTT = activated partial thromboplastin time; INR = international normalized ratio; SBP = systolic blood pressure.
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epinephrine-containing local anesthetics in THC placement procedure. Presence of PB complication was statistically significantly lower in epinephrine-containing local anesthetics group. Clinical implications of this finding would be that it could reduce the need for manual compression and, in turn, save time for the relevant healthcare personnel, and improve patient comfort. In addition, the dressing could remain dry, resulting in a faster wound healing and a marked reduction in wound site infection rates. 27, 28 However, epinephrine has a few significant side effects and there are in turn some limitations due to the potential dose-related cardiac effects. 10 Therefore, the optimal concentration of epinephrine for the prevention of PB should carefully be determined. Yang et al. compared the patients using 2.5, 5, or 10 μg/mL epinephrine for scalp incisions and concluded that all would elicit the higher highest mean arterial pressure with the same lowest mean arterial pressure and the same excellent hemostasis. 29 In the study of Shoroghi et al. the results of changing the epinephrine dose in local anesthetics were analyzed and 1:50,000 epinephrine dose was found to have the optimal. 6 Karm et al. found that an increase in BP and HR was associated with an increase in the dose of epinephrine. There was no difference between the groups with epinephrine at 1:80,000 concentrations and 1:200,000 concentrations in terms of both adverse effect and efficacy (2.0 AE 0.1 in the L80 group and 2.2 AE 0.1 in the L200 group, P = 0.206). Therefore, it was concluded that use of the epinephrine at 1:200,000 in hemodynamically unstable patients is safer. 12 We used 1:80,000 concentration of epinephrine and found it to be successful; the same study can be done with different doses of epinephrine and the procedure can be drawn to much safer doses. We observed no significant cardiovascular disturbance in any of the patients. However, we observed a decrease in SBP after local anesthesia with the epinephrine, as in some cases shown in previous reports, 25, 30, 31 which may indicate the safety of the technique.
Prilocaine and lidocaine are both medium-duration, amide-linked local anesthetics. Although the physicochemical properties of prilocaine and lidocaine used in our study are quite similar, there are minor differences in their pharmacokinetic parameters. The volumes of drug distribution at steady state and clearance of prilocaine is greater than that of lidocaine. 32 When administered at the same doses, peak plasma levels and the terminal half-life of lidocaine are higher than prilocaine. However, time to reach maximum concentration is the same for both. This is explained by the larger volume of distribution of prilocaine and the higher clearance compared to lidocaine. 33, 34 Besides the lipophilic nature of the two medium-duration local anesthetics is almost the same while their water solubility slightly differs. 35 In a study by Wahl et al., it was concluded that there is no difference in pain response between injection of prilocaine plain and that of lidocaine with 1:100,000 epinephrine. 36 The maximum recommended dose for lidocaine in the European countries is 200 mg without epinephrine and 500 mg of lidocaine is allowed if epinephrine (5 μg/mL) is added. The maximum recommended doses for prilocaine in the European countries are 400 and 600 mg with and without epinephrine, respectively. 32 Our study was retrospective in nature and therefore suffers from the limitations of such studies. First limitation related to that is the lack of a true control group, in other words, the patients treated only with lidocaine. But this distinction can be overlooked because prilocaine and lidocaine are both moderate acting local anesthetics and due to the similarity of their pharmacokinetic properties. The second one is the lack of postoperative coagulation parameters (aPTT, INR). A parameter other than the minute measurement could have been used to quantitatively evaluate the amount of PB (number of sponges). 8 However, when we look at similar studies in the past, we see that such subjective measures were used (point Likert categorical scale). 5, 7, 8 Furthermore, this is a single-center study with a small population and short follow-up.
CONCLUSION
Local infiltration of epinephrine-containing lidocaine before THC insertion results in less PB compared to plain local anesthetic solutions. Nonetheless, the maximum suggested dosage and contraindications must be considered prior to its use. Additional investigations are needed in a larger sample size and taking different concentrations of epinephrine into consideration.
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